Standard BioTools Inc.(LAB)

$0.91▼-0.01 (-1.13%)

Standard BioTools Inc.(LAB)

NASDAQ

$0.91▼-0.01 (-1.13%)

Overview Intelligence Chart Fundamentals Key Metrics Earnings Growth Analysts Financials Insiders Institutional

Analyst Sentiment

Analysts lean bullish — 67% recommend buying.

Consensus Rating

Buy

9 analysts·Limited coverage

67%

Rating Distribution

Strong Buy

00%

Buy

667%

Hold

333%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 258% higher.

Bear Case

$3.25

+258%

Consensus

$3.25

+258%

Bull Case

$3.25

+258%

Price Range9 analysts

Low

Consensus

High

$3.25

Current Target

Current Price

$0.91

Upside to Target

$2.34

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+2.58%

EPS—

FY2028

Rev+4.26%

EPS—

Earnings Surprises

Recent Analyst Actions

Apr 4, 2024Jefferies

Jefferies Starts Standard BioTools Inc (LAB) at Buy, 'Platform Building & Setting a New Standard'

Target:$3.25

+22.2%from $2.66

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance